drugset / Trial / NCT04325594
The Application of the Umbilical Cord Mesenchymal Stem Cells in the Complex Treatment of Non-ischemic Heart Failure
Phase 1/2
Completed
30 enrolled
The Research-Clinical Center for Cardiac Surgery and Transplantology LLP
State-Financed Health Facility "Samara Regional Medical Center Dinasty" · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this prospective single-arm clinical study was to evaluate the safety and potential efficacy of intracoronary administration of allogeneic umbilical cord-derived mesenchymal stromal cells (MSCs) as an addition to standard medical therapy in patients with chronic non-ischemic heart failure.
Timeline
- Start
- 2020-03-01
- Primary completion
- 2023-01-01
- Completion
- 2023-04-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | human umbilical cord mesenchymal stem cells | Cell therapy | 1e+07 cells | Other |